News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wolff Stefani
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/11/2023 |
4
| Wolff Stefani (Director) has filed a Form 4 on Rain Oncology Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.21, valued at
$42.4k
|
|
| 05/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Wolff Stefani (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Granted 20,000 options to buy
@ $2.44, valued at
$48.8k
|
|
| 08/10/2022 |
4
| Wolff Stefani (EVP and COO) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 110,375 options to buy
@ $18.5, valued at
$2M
|
|
| 08/02/2022 |
4
| Wolff Stefani (EVP and COO) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Sold 356 shares
@ $15.67, valued at
$5.6k
Exercised 962 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| Wolff Stefani (EVP and COO) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Sold 330 shares
@ $11.75, valued at
$3.9k
Exercised 962 restricted stock units
@ $0 |
|
| 01/21/2022 |
4
| Wolff Stefani (EVP and COO) has filed a Form 4 on Nurix Therapeutics, Inc.|
Txns:
| Granted 34,631 options to buy
@ $19.49, valued at
$675k
Granted 15,392 restricted stock units
@ $0 |
|
| 05/18/2021 |
4
| Wolff Stefani (Director) has filed a Form 4 on Rain Therapeutics Inc.|
Txns:
| Granted 24,000 options to buy
@ $15.33, valued at
$367.9k
|
|
| 04/22/2021 |
3
| Wolff Stefani (Director) has filed a Form 3 on Rain Therapeutics Inc. |
| 09/28/2020 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Gifted 5,504 shares
@ $0
Unknown transaction of 13,592 shares
@ $100, valued at
$1.4M
Disposed/sold 30,056 options to buy
@ $4.542, valued at
$136.5k
Disposed/sold 16,843 options to buy
@ $7.2671, valued at
$122.4k
Disposed/sold 22,017 options to buy
@ $11.3549, valued at
$250k
Disposed/sold 55,042 options to buy
@ $17, valued at
$935.7k
Disposed/sold 60,000 options to buy
@ $35.42, valued at
$2.1M
Disposed/sold 55,000 options to buy
@ $67.31, valued at
$3.7M
|
|
| 06/17/2020 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 400 shares
@ $59.8925, valued at
$24k
Sold 5,004 shares
@ $60.8095, valued at
$304.3k
Sold 100 shares
@ $61.368, valued at
$6.1k
|
|
| 06/17/2020 |
4/A
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 1,754 shares
@ $45.7196, valued at
$80.2k
Sold 3,750 shares
@ $46.3569, valued at
$173.8k
|
|
| 06/17/2020 |
4/A
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 4,205 shares
@ $49.2903, valued at
$207.3k
Sold 1,300 shares
@ $49.8654, valued at
$64.8k
|
|
| 03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2019 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Sold 4,205 shares
@ $49.2903, valued at
$207.3k
Sold 1,300 shares
@ $49.8654, valued at
$64.8k
Exercised 5,505 options to buy
@ $4.542, valued at
$25k
|
|
| 03/08/2019 |
4
| Wolff Stefani (Chief Development Officer) has filed a Form 4 on Principia Biopharma Inc.|
Txns:
| Granted 60,000 options to buy
@ $35.42, valued at
$2.1M
|
|
| 09/13/2018 |
3
| Wolff Stefani (Senior VP of Strategy and Ops) has filed a Form 3 on Principia Biopharma Inc. |
|
|